Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Clinical trial NCT06533722 · COMPLETED

Trial details

NCT number: NCT06533722
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative Metastatic Breast Cancer

Start date: 2024-08-04
Primary completion: 2024-09-20
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.